Literature DB >> 30386723

Osteosarcoma presenting with malignant pleural effusion in a 55 year old.

Kritika Krishnamurthy1, Sarah Alghamdi1, Jyotsna Kochiyil2, George F Bruney3, Robert J Poppiti4.   

Abstract

Osteosarcoma is the most common primary malignant neoplasm of the bone with over 60% of the cases occurring in patients 10-20 years old. Osteosarcoma rarely occurs in patients older than 40 years of age, most commonly in bones affected by preexisting conditions such as Paget's disease, prior irradiated bone or osteogenesis imperfecta. Osteosarcoma presenting with pleural metastases is very rare. Herein we describe a case of metastatic osteosarcoma presenting with pleural effusion due to underlying pleural metastases in a 55 year old woman.

Entities:  

Year:  2018        PMID: 30386723      PMCID: PMC6205353          DOI: 10.1016/j.rmcr.2018.10.017

Source DB:  PubMed          Journal:  Respir Med Case Rep        ISSN: 2213-0071


Introduction

Osteosarcoma is the most common primary malignant neoplasm of bone and has the second highest mortality rate among pediatric cancers [1]. It is most commonly diagnosed in patients in the second and third decades of life, with over 60% of the cases occurring in patients between the ages of 10–20 years [1]. Osteosarcomas respond dramatically to treatment however metastatic disease eventually develops in almost 25–30% of the patients with the lung being the most common site of metastases [2]. Osteosarcoma rarely occurs in patients older than 40 years of age, usually in bones affected by preexisting conditions such as Paget's disease, prior irradiated bone or osteogenesis imperfecta [3]. The prognosis in older patients is worse as compared to younger patients. Studies have shown that prognosis worsens with age among adults while being age-independent in children [4]. This has been attributed to the more central location of tumors and decreased ability to tolerate high dose chemotherapy among older adults [5]. Osteosarcoma presenting with pleural metastases is extremely rare. Herein we describe a case of metastatic osteosarcoma presenting with pleural effusion due to pleural metastases in a 55 year old woman.

Case report

A 55 year old woman presented with persistent shortness of breath and right lower limb weakness. CT of the chest revealed a right pleural effusion with thickened, focally calcified irregular pleura on the right side and a calcified nodule in the left lung (Fig. 1). CT of the abdomen revealed a large expansile destructive lytic lesion involving the right iliac bone with a significant soft tissue component (Fig. 2). Areas of matrix calcifications were seen within with the Codman triangle, measuring 13 × 11 × 8 cm with aggressive lamellated and sunburst type periosteal reaction.
Fig. 1

CT scan of thorax, axial section soft tissue window, showing extensive calcified pleural metastases on the right side (arrow) and a calcified nodule in the left suggesting metastasis (long arrow).

Fig. 2

CT scan axial section in bone window showing lesion involving the right iliac crest with soft tissue component (arrow).

CT scan of thorax, axial section soft tissue window, showing extensive calcified pleural metastases on the right side (arrow) and a calcified nodule in the left suggesting metastasis (long arrow). CT scan axial section in bone window showing lesion involving the right iliac crest with soft tissue component (arrow). A right lateral thoracotomy was performed and the pleural effusion was drained. The pleural mass was biopsied. Microscopic examination revealed a diffuse proliferation of spindle to oval shaped cells showing moderately pleomorphic, hyperchromatic nuclei and frequent mitoses with associated deposition of abundant osteoid. The cells exhibited extreme pleomorphism and nuclear atypia (Fig. 3). The pleural biopsy was highly suggestive of high grade osteosarcoma and in the presence of radiological evidence of osteosarcoma in the right ileum, the diagnosis of metastatic osteosarcoma was made.
Fig. 3

400X view showing pleomorphic cells with mitoses and osteoid formation.

400X view showing pleomorphic cells with mitoses and osteoid formation.

Discussion

Osteosarcoma is an aggressive primary bone tumor arising from primitive bone-forming cells. A number of variants of osteosarcoma have been documented. These include telangiectatic, multifocal, parosteal, and periosteal types in addition to the conventional osteoblastic, chondroblastic, and fibroblastic types [6]. The metastases of osteosarcoma are typically hematogenous and microscopic metastases are usually present at the time of diagnosis. At presentation, 10% of the patients have distant metastases, the most common sites being lung and bone [7]. Isolated pleural metastases in the absence of ipsilateral lung deposits are exceedingly rare [8]. According to the Japan Autopsy Annual Database, 643 patients died of osteosarcoma between 1981 and 2002 in Japan, of whom, only 78 (12.1%) patients had pleural metastases [9]. The most commonly reported CT impression is of single or multiple pleural based nodules with concomitant lung parenchymal metastases. Diffuse pleural thickening with a mass lesion, as seen in our case is a rarely reported incidence. Also there are no conclusive published data regarding the occurrence of pleural effusion in patients with osteosarcoma. Probable routes of pleural metastases in patients with osteosarcoma may be through direct contact of pleura with the lung metastases or hematogenous spread [10]. It is not possible to track the definite route of pleural metastases. The presence of a pleural based mass, without any radiologically evident ipsilateral lung nodules favors hematogenous spread of the tumor in our patient, however microscopic metastases in the ipsilateral lung cannot be ruled out. Also the lack of pleural metastases on the opposite side despite the presence of metastatic lung nodules speaks against a local spread. Overall management and prognosis in cases of metastatic osteosarcoma is determined by the number, site and size of the metastases [1]. Complete surgical resection is a prerequisite for cure and improves the survival of the patient. Osteosarcoma presenting with metastatic parietal pleural lesions, either in isolation or in association with a lung lesion, should be completely resected with free pleural margins [11]. Patients with unresectable disease may benefit from radiotherapy [12].

Conclusion

Osteosarcoma presenting with pleural effusion due to pleural metastases is extremely rare. Surgical resection of the localized pleural tumor improves patient outcome in osteosarcoma with pleural metastases. In patients with undiagnosed pleural effusion and radiological suspicion of osteosarcoma, thoracoscopy is recommended to identify and biopsy pleural metastases for establishing the definitive diagnosis.

Declarations

The work described has been carried out in accordance with the code of ethics of the world medical association (Declaration of Helsinki). The authors have no conflicts of interest to disclose.

Declarations of interest

None.

Conflicts of interest-

We wish to confirm that there are no known conflicts of interest associated with this publication and there has been no significant financial support for this work that could have influenced its outcome.
  11 in total

1.  Pleural Metastasis of Osteosarcoma.

Authors:  Edson Marchiori; Miriam Menna Barreto; Gláucia Zanetti
Journal:  Ann Thorac Surg       Date:  2018-02       Impact factor: 4.330

2.  Prognostic factors among 130 patients with osteosarcoma.

Authors:  L Pochanugool; T Subhadharaphandou; M Dhanachai; P Hathirat; D Sangthawan; R Pirabul; S Onsanit; N Pornpipatpong
Journal:  Clin Orthop Relat Res       Date:  1997-12       Impact factor: 4.176

3.  Primary osteosarcoma in adults older than 40 years.

Authors:  Belen Carsi; Michael G Rock
Journal:  Clin Orthop Relat Res       Date:  2002-04       Impact factor: 4.176

4.  Kissing pleural metastases from metastatic osteosarcoma of the lung.

Authors:  Takeshi Mori; Masakazu Yoshioka; Kazunori Iwatani; Hironori Kobayashi; Kentaro Yoshimoto; Hiroaki Nomori
Journal:  Ann Thorac Cardiovasc Surg       Date:  2006-04       Impact factor: 1.520

Review 5.  Radiation and pagetic osteogenic sarcomas.

Authors:  J H Healey; D Buss
Journal:  Clin Orthop Relat Res       Date:  1991-09       Impact factor: 4.176

6.  Chemotherapy for nonmetastatic osteogenic sarcoma: the Memorial Sloan-Kettering experience.

Authors:  P A Meyers; G Heller; J Healey; A Huvos; J Lane; R Marcove; A Applewhite; V Vlamis; G Rosen
Journal:  J Clin Oncol       Date:  1992-01       Impact factor: 44.544

7.  Improved prognosis of children with osteosarcoma metastatic to the lung(s) at the time of diagnosis.

Authors:  N M Marina; C B Pratt; B N Rao; S J Shema; W H Meyer
Journal:  Cancer       Date:  1992-12-01       Impact factor: 6.860

8.  Osteosarcoma recurrences in pediatric patients previously treated with intensive chemotherapy.

Authors:  M D Tabone; C Kalifa; C Rodary; M Raquin; D Valteau-Couanet; J Lemerle
Journal:  J Clin Oncol       Date:  1994-12       Impact factor: 44.544

9.  Osteosarcoma relapse as pleural metastasis.

Authors:  Debabrata Saha; Kaushik Saha; Arpita Banerjee; Debraj Jash
Journal:  South Asian J Cancer       Date:  2013-04

10.  The metastatic patterns of osteosarcoma.

Authors:  G M Jeffree; C H Price; H A Sissons
Journal:  Br J Cancer       Date:  1975-07       Impact factor: 7.640

View more
  3 in total

1.  Diffuse pleural metastases of osteosarcoma detected by bone scan.

Authors:  André Marcondes Braga Ribeiro; Eduardo Nobrega Pereira Lima; Daniel Habib Issa Lima
Journal:  World J Nucl Med       Date:  2020-08-22

2.  Unexpected Metastasis to Breast, Lymph Node, Subcutaneous, Abdominal Wall, Intraabdominal, and Bone in Osteogenic Osteosarcoma: An Unusual Presentation on Bone Scintigraphy.

Authors:  Anjali Meena; Hardik Veerwal; Vandana K Dhingra; Mohit Dhingra
Journal:  Indian J Nucl Med       Date:  2022-03-25

3.  Osteogenic Sarcoma Presenting with Skip, Lymph Nodal, Pulmonary, Pleural Metastases and Malignant Effusion: An Unusual Appearance on Bone Scan.

Authors:  Neeraja Bollampally; Venkata Subramanian Krishnaraju; Ashwani Sood; Sameer Aggarwal; Bhagwant Rai Mittal
Journal:  Indian J Nucl Med       Date:  2021-03-04
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.